Key result
PTMC linked to ~0.48 cm² gain in mitral valve area and durable symptom relief.
Why the study?
The study was conducted to evaluate the long-term clinical and echocardiographic outcomes of percutaneous trans mitral balloon commissurotomy in patients with severe mitral stenosis.
Does percutaneous transmitral commissurotomy provide sustained clinical and echocardiographic improvement in patients with severe mitral stenosis over long-term follow-up?
Cohort (n=103)
No
Does percutaneous transmitral commissurotomy provide sustained clinical and echocardiographic improvement in patients with severe mitral stenosis over long-term follow-up?
Answers are grounded in this paper and cite their sources.
Percutaneous transmitral commissurotomy provides durable long-term symptomatic and echocardiographic improvements in appropriately selected young patients with severe rheumatic mitral stenosis.
Objectives: To study the long term clinical and echocardiographic outcomes of percutaneous Trans mitral balloon commissurotomy (PTMC) performed in patients with severe mitral stenosis. Methodology: Total 103 patients were enrolled in this study. Their PTMC procedure was performed between the years 2015 to 2019. Those patients who returned for follow-up in the year 2021 were enrolled. At the time of follow-up their clinical and echocardiographic parameters were recorded. Results: The mean age was 27.44±6.26 years and 97 (94.2%) of them were female. Mitral valve area was improved significantly, planimetry; 0.813±1.39 vs. 1.288±0.21cm2 and PHT; 0.871±0.13 vs. 1.336±0.19 cm2 between baseline and follow-up, respectively. Pressure gradient across mitral valve also improved 7.233±2.81 vs. 14.407±0.92 mmHg between baseline and follow-up, respectively. Pulmonary artery pressures were also reduced significantly 24±0.27 vs. 55±2.41 mmHg as well as the right ventricular systolic pressures 24.4±2.94 vs. 62.34±10.98 mmHg between baseline and follow-up, respectively. At follow-up, 70.9% had NYHA I class, 16.5% had NYHA II class, 11.7% had NYHA III class, and 1% had NYHA IV class compared to 6.8%, 5.8%, 33.9%, and 53.4% pre-procedure, respectively. Conclusion: Long term follow-up of patients after PTMC showed satisfactory outcomes both clinically, as evident from improvement in NYHA functional class, and from echocardiographic stand point with sustained increase in mitral valve area over the period of years. Overall the results of PTMC performed in patients with severe mitral stenosis are satisfactory.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2023) conducted a cohort in Severe mitral stenosis (n=103). Percutaneous transmitral commissurotomy vs. Baseline (pre-procedure) was evaluated on Mitral valve area (planimetry) at long-term follow-up (p=<0.001). Percutaneous transmitral commissurotomy significantly improved mitral valve area from 0.813 cm2 to 1.288 cm2 (p<0.001) and drastically reduced severe symptoms at long-term follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: